Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001731122-23-001776
Filing Date
2023-10-02
Accepted
2023-10-02 09:28:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 425 e5076_425.htm 425 21619
2 EXHIBIT 99.1 e5076_ex99-1.htm EX-99.1 25728
  Complete submission text file 0001731122-23-001776.txt   49668
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filed by) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-38758 | Film No.: 231298154
SIC: 2834 Pharmaceutical Preparations